Published: · Last updated: · Last reviewed:
Is Foundayo Worth It? An Honest 2026 Verdict on Cost, Results, and Who It's For
The verdict in 40 seconds
Foundayo (orforglipron) is the only FDA-approved GLP-1 pill for weight loss you can take any time, with or without food — no needles, starting at $149 a month.
It's worth it for people who want a pill instead of a shot, can't follow strict morning-fasting rules, and want one of the lowest-priced brand-name GLP-1s to start. It's not the best choice if maximum weight loss is your top priority — injectable Zepbound roughly doubles Foundayo's average result in trials.
The part nobody puts up front:
Foundayo's $149/month is just the starting dose. Your bill rises with each dose step, reaching about $299–$349 at maintenance. Year one totals roughly $3,300–$3,700 cash — not $1,788. The rest of this page gives you the real number.
Jump to: What we verified · Real cost · Weight loss · vs Wegovy / Zepbound · Switching · Side effects · Who shouldn't take it · How to get it · Insurance & Medicare · FAQ
Foundayo may be worth it — or not — depending on you
| Foundayo may be worth it if… | Foundayo may not be worth it if… |
|---|---|
| You want an FDA-approved GLP-1 you swallow, not inject | Maximum average weight loss is your #1 goal |
| Needles are the thing stopping you | You're already losing well on Wegovy or Zepbound |
| You can't do a strict empty-stomach morning routine | You take oral birth control and don't want backup-method planning |
| You travel, work shifts, or skip breakfast | You take simvastatin over 20 mg or strong drug-interaction meds |
| You want a low starting price ($149/month) | You qualify for the $50/month Medicare GLP-1 Bridge (then start there) |
The fast verdict, by who you are
| Your situation | Is Foundayo worth it? | Best next step |
|---|---|---|
| “No needles, no morning fasting ritual.” | Usually yes, if you qualify | Check eligibility on Ro (sponsored affiliate link, opens in a new tab) |
| “I want the most weight loss possible.” | Probably not first | Compare Zepbound |
| “I'm already losing weight on a shot.” | Usually don't switch | Talk to your provider first |
| “I'm on Medicare Part D.” | Don't cash-pay first | Check Medicare Bridge eligibility |
| “Foundayo vs. the Wegovy pill?” | Depends: routine vs. results | Compare side by side below |
Affiliate link · medication and membership billed separately
What we actually verified before giving this verdict
Before we call anything “worth it,” we check it against primary sources — the FDA, the official drug label, the manufacturer's own pricing, and Medicare rules — not social media hype. Here's exactly what we confirmed and how often we re-check it.
| What we checked | Source | What we found (June 22, 2026) | Re-check cadence |
|---|---|---|---|
| Approval status & date | FDA; NDA 220934 | FDA approved Foundayo on April 1, 2026 | Quarterly or on FDA alert |
| Indication, dosing, warnings, interactions | DailyMed (official FDA label) | Once daily, any time, with or without food; max 17.2 mg; boxed warning for thyroid tumors; MTC/MEN 2 and hypersensitivity contraindications; birth-control, simvastatin, CYP3A4 warnings | Quarterly |
| Trial weight-loss results | DailyMed label; Eli Lilly trial data | 11.1% average at top dose at 72 weeks (no-diabetes trial) | When new trials publish |
| Cash price by dose | LillyDirect / foundayo.lilly.com | $149-$349/month by dose; $299 on top doses with on-time refills | Monthly |
| Insurance & savings card | foundayo.lilly.com coverage page | As low as $25/month with commercial coverage + card (caps apply) | Monthly |
| Medicare access & rules | CMS Medicare GLP-1 Bridge pages | $50/month for eligible Part D members, July 1, 2026 - Dec 31, 2027 | Monthly through launch |
| Provider access | Ro press release; Ro product pages | Foundayo available on Ro at $149/month medication price (membership separate) | Monthly |
| Real-world reviews | Drugs.com (public reviews) | Early and limited — about 5.8/10 from roughly 6 reviews | Monthly |
Is Foundayo worth it in 2026?
Foundayo is worth it for the person who values a flexible, FDA-approved GLP-1 pill more than chasing the biggest weight-loss number. The honest trade is simple: Foundayo is easier to fit into a normal day than the Wegovy pill, but the trial data do not make it the strongest GLP-1 for average weight loss. For the right person, “easiest to stick with” beats “strongest on paper.”
Foundayo is the newest pill, and it removes the three things people hate most about GLP-1s better than any of them: no needle, no empty-stomach rule, and no timing window — just one tablet a day, swallowed whole, whenever works for you. It's a small-molecule drug, meaning it's built from simple, sturdy chemistry rather than a fragile protein like the shots. That's the trick that lets it survive your stomach with no special timing. The Wegovy pill is a protein-based drug, which is why it needs the empty-stomach routine.
Our one honest admission, up front
Foundayo does not produce the most weight loss. In its main trial, people on the top dose lost about 11.1% of their body weight over 72 weeks. Injectable Zepbound (tirzepatide) reached about 20.9% in its trial — roughly double. So if the single biggest number is all that matters to you, and a weekly shot doesn't scare you off, Zepbound is the better pick — and we'll point you there.
But Foundayo isn't trying to win the “biggest number” contest. It's trying to win the “I'll actually do this” contest. Think about why “the pill” beat other forms of birth control: it won on routine and freedom, not raw strength. Same idea here. For a needle-averse person, a flexible daily pill that delivers around 11% is worth far more than a shot they quit after two months. So the real question isn't “is Foundayo strong enough?” It's “is Foundayo's convenience worth a few percentage points of weight loss — for me?”
How much does Foundayo cost? The $149 headline vs. your real first-year cost
Foundayo's “$149/month” is real — but it's the starting dose, not what you'll pay all year. Because the dose climbs every month or so, your monthly bill rises with it. Most people pay between $149 and $349 a month depending on dose, which works out to roughly $3,300 in the first year when paying cash.
Foundayo cash price by dose (LillyDirect / Ro)
| Month (typical) | Dose | Cash price | Note |
|---|---|---|---|
| Month 1 | 0.8 mg | $149 | Starting dose |
| Month 2 | 2.5 mg | $199 | First step up |
| Month 3 | 5.5 mg | $299 | Step up |
| Month 4 | 9 mg | $299 | Step up |
| Month 5 | 14.5 mg | $299* | *$299 only if you refill within 45 days; otherwise $349 |
| Month 6+ | 17.2 mg (max) | $299* | *$299 only if you refill within 45 days; otherwise $349 |
Source: Foundayo.lilly.com / LillyDirect pricing, verified June 22, 2026.
What you'll actually pay in year one
Assume a typical ramp — months 1–4 as above, then months 5–12 at a higher dose with on-time refills:
- Self-pay, refilling on time: about $3,338 for 12 months (~$278/month averaged).
- Self-pay, missing the 45-day window on top doses: about $3,738 (~$311/month).
- Commercial insurance + savings card: as low as $25/month — but the card caps at $100/month and $1,000/year, allows up to 10 fills, and expires December 31, 2026. Confirm your real copay.
- Medicare Part D (GLP-1 Bridge): $50/month for eligible members from July 1, 2026. See the Medicare section below.
The 45-day refill rule most pages miss
Lilly automatically applies a $299 offer to your first order of 14.5 mg or 17.2 mg Foundayo, saving you $50/month at the doses that matter most. To keep that $299 price on subsequent refills, you must reorder within 45 days of your previous delivery date. Miss the window and the price jumps to $349. Set a refill reminder.
Foundayo First-Year Cost & Fit Estimator
Put in how you'll pay, your target dose, and a few quick fit questions. In about 30 seconds you get an estimated 12-month total and a personalized next step. (“$149” is just the starting dose — this gives you the real number for your situation.)
Foundayo First-Year Cost & Fit Estimator
Estimate your real 12-month cost and get a personalized next step — in about 30 seconds.
How will you pay?
Target maintenance dose
Not sure? Choose 17.2 mg (the max dose — what most trials report).
Will you refill within 45 days? (affects top-dose pricing)
Which of these are true for you?
How much weight can you lose on Foundayo?
In Foundayo's main 72-week trial (in adults without diabetes), the most honest single number is about 11% of body weight at the top dose — for someone who weighs 230 pounds, that's roughly 25 pounds. That's real, meaningful weight loss. It's also lower than the strongest injectables.
Foundayo average weight loss at 72 weeks — Trial 1 (no diabetes)
| Group | Avg. body-weight change | About how many pounds* |
|---|---|---|
| Placebo (no drug) | -2.1% | ~5 lbs |
| Foundayo 5.5 mg | -7.4% | ~17 lbs |
| Foundayo 9 mg | -8.3% | ~19 lbs |
| Foundayo 17.2 mg (top dose) | -11.1% | ~25 lbs |
*Based on the trial's average starting weight (~225–230 lbs). Your results depend on your starting weight, dose, diet, and activity. These are averages — some people lose more, some less. Source: DailyMed label; Eli Lilly trial data.
- More than half of people on the top dose lost at least 10% of their weight, and roughly 1 in 3 lost at least 15%.
- People who stayed on treatment at the highest dose lost about 12.4% (~27 pounds) — slightly higher than 11.1%, which counts everyone including early stoppers.
- It builds slowly. Appetite changes can show up in the first few weeks, but the 72-week trial is the real measure. Foundayo is meant to be used with a reduced-calorie diet and more physical activity — not on its own.
Foundayo vs. the Wegovy pill vs. Zepbound: which is worth it for you?
If you want the most weight loss, Zepbound (a weekly shot) leads. If you want a pill with no timing rules at a low starting price, Foundayo wins. The Wegovy pill is the other oral option — it loses a little more weight on average, but you have to take it on an empty stomach every morning. All are FDA-approved. The best one is the one you'll actually keep taking.
| Option | Form & schedule | Dosing rules | Avg. weight loss (top dose, its trial) | Cash price | Best fit |
|---|---|---|---|---|---|
| Foundayo (orforglipron) | Daily pill | None — any time, with or without food | ~11% (72 wks) | $149–$349/mo ($299 on top doses with on-time refills) | Wants the easiest FDA-approved pill |
| Wegovy pill (oral semaglutide 25 mg) | Daily pill | Morning, empty stomach, ≤4 oz water, wait 30 min | ~14% (64 wks) | $149/mo to start; more at higher doses | Wants a pill and can do the morning routine |
| Wegovy injection (2.4 mg) | Weekly shot | None | ~15% | Varies | Wants a proven weekly injectable |
| Zepbound (tirzepatide 15 mg) | Weekly shot | None | ~21% (72 wks) | $299–$699/mo | Wants the strongest average result |
Sources: DailyMed; Eli Lilly; Novo Nordisk; Zepbound pricing (LillyDirect) — verified June 2026. Cross-trial comparisons are directional, not head-to-head.
The simple decision rule
- Pick Foundayo if avoiding needles or skipping the morning fasting ritual is the real blocker — and you're okay trading a few points of weight loss for that freedom.
- Pick the Wegovy pill if you want an oral GLP-1, can reliably take it first thing on an empty stomach, and want a slightly higher average result.
- Pick Zepbound if maximum average weight loss matters more than avoiding a weekly shot.
- Check the Medicare GLP-1 Bridge first if you're an eligible Medicare Part D member — the math may beat all of the above.
Affiliate link
Should you switch to Foundayo if you're already on Zepbound or Wegovy?
It depends on why you'd switch. If your current shot is working and you tolerate it, don't switch to Foundayo just for convenience — you may regain some weight. But if needles, cold storage, cost, or simply staying on it are the reasons you might quit, Foundayo can be a reasonable move.
Lilly ran a study called ATTAIN-MAINTAIN that did exactly this: it took people who'd lost weight on injectable semaglutide or tirzepatide and moved them to oral orforglipron. The pill maintained weight loss better than placebo — so for someone who'd otherwise stop injecting, switching to a pill they'll actually keep taking can protect their progress. The catch: people coming off tirzepatide/Zepbound tended to give back a bit more than those coming off semaglutide/Wegovy, because you're stepping down from a stronger drug.
| Your situation | Smart move |
|---|---|
| Losing well and tolerating your shot | Usually stay — don't trade results for convenience |
| Needles or refrigeration are why you might quit | Worth discussing a switch; a pill you'll keep taking beats a shot you stop |
| Cost is the problem | Compare cash and Medicare options before switching meds |
| Cravings came back on Foundayo's starter dose | Normal early on — judge it only after your provider steps up the dose |
Free 60-second quiz · personalized next step
Foundayo side effects and the hidden frictions nobody warns you about
The most common Foundayo side effects are stomach-related — nausea, constipation, diarrhea, and vomiting — and they're usually worst when you start or step up a dose, then ease over time. About 3–6% of people in trials stopped because of stomach side effects. Foundayo also carries a boxed warning (the FDA's strongest warning) for a possible risk of thyroid tumors.
Most common side effects by dose (% of people, from the FDA label)
| Side effect | Placebo | 5.5 mg | 9 mg | 17.2 mg |
|---|---|---|---|---|
| Nausea | 10% | 26% | 34% | 35% |
| Constipation | 9% | 20% | 27% | 24% |
| Diarrhea | 11% | 21% | 23% | 25% |
| Vomiting | 4% | 13% | 21% | 24% |
| Indigestion (dyspepsia) | 4% | 12% | 16% | 13% |
| Belly pain | 7% | 13% | 14% | 14% |
| Headache | 7% | 8% | 9% | 9% |
| Bloating | 3% | 7% | 9% | 8% |
| Fatigue | 4% | 6% | 7% | 9% |
| Burping | 1% | 6% | 8% | 8% |
| Acid reflux (GERD) | 2% | 6% | 6% | 7% |
| Gas (flatulence) | 2% | 5% | 6% | 6% |
| Hair loss | 2% | 4% | 4% | 5% |
Source: DailyMed official FDA label for Foundayo (orforglipron). Most stomach side effects are mild to moderate and peak during dose increases.
The hidden frictions most pages skip
| Hidden friction | Why it matters | What to do |
|---|---|---|
| Birth control pills | Foundayo can lower how well oral birth control works | The label says use a non-pill method or add a barrier method for 30 days after starting and 30 days after each dose increase |
| Simvastatin | Foundayo raises simvastatin levels in your blood | Don't take more than 20 mg of simvastatin a day with Foundayo |
| Strong CYP3A4 meds | Some antibiotics, antifungals, seizure or HIV meds can raise or lower Foundayo's levels | Strong inhibitors cap your dose at 9 mg; strong inducers should be avoided — review with a pharmacist |
| Other daily pills | Foundayo slows stomach emptying, which can change how other pills absorb | Tell your provider every medication you take |
| The 45-day refill rule | Miss the window and your top-dose price jumps from $299 to $349 | Set a refill reminder |
You don't need to memorize CYP3A4 — just bring your full medication list to your appointment and let your provider or pharmacist check for clashes. That one step prevents almost every interaction problem on this list.
Who should not take Foundayo?
Some people should not take Foundayo, and a few more should only start after a provider signs off. From the FDA label:
| Hard no — don't take Foundayo | Talk to your provider first |
|---|---|
| You or a close family member has had medullary thyroid cancer or MEN 2 | History of pancreatitis or gallbladder disease |
| You've had a serious allergic reaction to orforglipron or any Foundayo ingredient | You take insulin or a sulfonylurea (low-blood-sugar risk) |
| You're on another GLP-1 medication (the label says don't combine) | Severe liver problems or severe gastroparesis (slow stomach) |
| Diabetic eye disease (retinopathy) | |
| Planned surgery or anesthesia — tell your care team | |
| You take interacting medications (simvastatin, strong CYP3A4 drugs) |
On pregnancy and breastfeeding: Foundayo should be stopped when pregnancy is recognized, and it is not recommended while breastfeeding. If you could become pregnant, use effective contraception — and remember the birth-control-pill caution above.
None of the “talk to your provider first” items automatically rules you out. If a hard “no” applies to you, Find My GLP-1 Path can point you toward treatment paths that fit your health history.
Is there a cheaper compounded or generic Foundayo?
No. There is no FDA-approved generic and no legitimate compounded version of orforglipron.
Foundayo is brand-name, patent-protected, and too new for a generic. If a website advertises “compounded orforglipron” or “generic Foundayo,” that is a red flag — the substance doesn't legally exist, which means you can't trust what's in it. The legitimate ways to pay less are LillyDirect's cash prices, the Foundayo Savings Card with commercial insurance, or the Medicare GLP-1 Bridge if you're eligible. That's it.
How to get Foundayo: Ro, LillyDirect, and where to start
Foundayo is prescription-only. The fastest paths are a telehealth visit (like Ro, where the medication starts at $149/month plus a membership fee), Lilly's direct-to-patient service (LillyDirect), or your own doctor sending a prescription to a pharmacy. A provider checks that you qualify, then the medicine ships to your door.
On paper, the FDA criteria are a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition — like high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or heart/artery disease. Any licensed prescriber can write it, but a provider still decides whether it's medically right for you.
Your access paths, compared honestly
| Path | What it is | Cost notes | Best for |
|---|---|---|---|
| Ro (our top pick here) | Telehealth visit + prescription + delivery; insurance concierge; free GLP-1 coverage checker | Medication at Lilly prices ($149–$349); membership separate — from $39 first month, then as low as $74/mo (annual) or $149/mo monthly | People who want guided online care and help with insurance |
| LillyDirect | Lilly's direct-to-patient pharmacy service; free home delivery | Same medication prices; no membership fee | People who want the lowest cash price and don't need a concierge |
| Retail pharmacy | CVS, Walgreens, Walmart, Costco, Amazon Pharmacy | Use insurance + savings card | People using commercial insurance |
| Sesame Care | Marketplace — choose your own provider | Visit fees vary | People who want to choose their clinician |
Why we put Ro first for Foundayo
Ro is an FDA-approved-medication path that carries Foundayo (and Zepbound) directly. It handles prior-authorization paperwork if you're using insurance, offers a free GLP-1 Insurance Coverage Checker, and gives you a clear picture of your real cost before committing. The honest catch: the membership fee is a separate line item on top of the medication — if you want the absolute cheapest cash price and don't need the hand-holding, LillyDirect is leaner. We'd rather tell you that than pretend Ro is the only option.
Affiliate link · medication and membership billed separately
Foundayo reviews: what real users say so far
Foundayo launched in April 2026, so reviews are still early and limited — an average around 5.8 out of 10 across roughly 6 public ratings on Drugs.com as of June 2026, with about half positive. The pattern is clear and useful: people love the no-needle, no-fasting convenience; the disappointed reviews mostly come from people still on the tiny starting dose or switching down from a stronger drug.
These are real, public reviews. We're sharing them as anecdotes, not proof — they're not evidence of how well Foundayo works or how safe it is, and your experience may differ.
Drugs.com, May 2026 — 10/10
“I don't like needles, so this option is fantastic.” — A reviewer who liked that Foundayo doesn't require an empty stomach and was seeing steady weight loss after some early nausea.
Drugs.com, June 2026 — 8/10
“Zero cravings and zero food noise.” — A reviewer who lost 12 pounds in the first month on the lowest dose, after a few days of nausea.
Drugs.com, May 2026 — 1/10
“It's not working at all.” — A reviewer who had lost 105 pounds on Zepbound, switched to Foundayo, and had to restart at 0.8 mg; cravings returned. This matches what the ATTAIN-MAINTAIN trial data show: stepping down from a stronger drug can mean a temporary setback.
Does insurance or Medicare cover Foundayo?
Insurance can change the answer completely. With commercial insurance plus the manufacturer savings card, you might pay as little as $25/month. And starting July 1, 2026, eligible Medicare Part D members may be able to get Foundayo for $50/month through the Medicare GLP-1 Bridge.
Commercial insurance
Coverage for weight-loss drugs is still rolling out in 2026, and many plans are deciding now. If your plan covers Foundayo, the Foundayo Savings Card can bring eligible commercially insured patients to as low as $25/month — but remember the limits: up to $100/month and $1,000/year in savings, up to 10 fills, and the card expires December 31, 2026. People on government plans (Medicare, Medicaid, VA, TRICARE) can't use the manufacturer card.
Medicare GLP-1 Bridge — $50/month from July 1, 2026
This is the one worth checking before you pay cash. The Medicare GLP-1 Bridge is a temporary federal program running July 1, 2026 through December 31, 2027 that gives eligible Part D members certain GLP-1s — including Foundayo — for a $50/month copay. Not everyone qualifies. To get the Bridge, you must:
- Be enrolled in a Medicare Part D plan, and
- Be taking the GLP-1 for weight loss (not diabetes, sleep apnea, or MASH — those use your regular Part D plan), and
- Meet one of these BMI + health checks (based on your weight when you first started GLP-1 treatment):
- BMI 35 or higher (qualifies on its own), or
- BMI 30 or higher with heart failure, hard-to-control high blood pressure, or chronic kidney disease, or
- BMI 27 or higher with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease.
A provider files a prior authorization to enroll you. The $50 copay does not count toward your Part D deductible or out-of-pocket maximum, and Extra Help (low-income subsidy) doesn't apply to it. The BMI check is based on your weight at the time you started, so losing weight later doesn't disqualify you.
If you qualify for the Bridge, $50/month beats every cash option on this page. See our Medicare GLP-1 Bridge guide for Foundayo for the full eligibility list and real out-of-pocket cost details before you decide.
The RX Index Worth-It Score for Foundayo
On our five-pillar framework, Foundayo scores strongest on clinical legitimacy and transparency (FDA-approved with a public label and published prices) and on access (available nationwide through several paths). It scores in the middle on cost (a low entry price, but dose increases and provider fees add up), and care quality depends on where you get it.
| RX Index pillar | Foundayo grade | Why |
|---|---|---|
| Clinical legitimacy | High | FDA-approved; full public label; prescription-only |
| Care quality | Depends on provider | Best with a legitimate telehealth or in-person provider offering ongoing care |
| Transparency | High | Published label, dosing, and dose-by-dose pricing |
| Access | Medium-high | Nationwide via LillyDirect, Ro, and pharmacies — but insurance and Medicare rules vary |
| Cost | Medium | Low entry price, but dose step-ups and membership fees raise the real total |
This is an editorial decision framework, not a medical rating or a star score. It's how we'd weigh Foundayo if a friend asked.
Bottom line: should you start Foundayo?
Start the Foundayo conversation if you want an FDA-approved GLP-1 pill, needles are your blocker, you can't follow a strict morning routine, and you can handle the dose-based cost. Don't choose it blindly if maximum weight loss, birth-control planning, interacting medications, or Medicare eligibility could point you somewhere better. Here's the whole decision in seven questions.
- Do you want an FDA-approved GLP-1 pill? If yes, compare Foundayo and the Wegovy pill.
- Is avoiding needles the main thing? If yes, Foundayo moves up your list.
- Can you take a pill first thing every morning on an empty stomach? If yes, the Wegovy pill is worth comparing. If no, Foundayo's flexibility matters more.
- Is the biggest possible weight loss your #1 goal? If yes, look at Zepbound first.
- Already losing well on a shot? Usually stay put — don't switch down just for convenience.
- On Medicare Part D? Check the Medicare GLP-1 Bridge criteria before paying cash.
- Do birth control, simvastatin, CYP3A4 meds, pregnancy, thyroid cancer history, or bad stomach issues apply? Talk to a clinician before starting.
If you've worked through those and Foundayo still fits, you have our honest blessing — this is a legitimate, FDA-approved option, and wanting the easier path is a perfectly good reason to choose it.
Affiliate link
Personalized recommendation · no email required
Foundayo FAQ
Is Foundayo FDA-approved?
Yes. The FDA approved Foundayo (orforglipron) on April 1, 2026, for adults with obesity (BMI 30 or higher) or adults who are overweight (BMI 27 or higher) with at least one weight-related medical condition, used alongside a reduced-calorie diet and increased physical activity. It is a prescription once-daily GLP-1 pill.
Is Foundayo worth it compared with the Wegovy pill?
It depends on your routine. Foundayo can be taken any time, with or without food, while the Wegovy pill must be taken in the morning on an empty stomach with a 30-minute wait. The Wegovy pill shows slightly higher average weight loss in its trial (about 14% vs. about 11%), so the choice comes down to convenience versus a small results edge. If you can reliably do the Wegovy pill's morning routine, it edges out Foundayo on weight loss. If you can't, Foundayo is the better fit.
Is Foundayo better than Zepbound?
Not if 'better' means the most weight loss. Zepbound (a weekly shot) produced about 21% average weight loss in its trial — roughly double Foundayo's 11%. But Foundayo may be better for someone who won't use injections or wants a simpler daily pill with no timing rules.
How much does Foundayo cost without insurance?
Cash prices run $149 for the 0.8 mg starting dose, $199 for 2.5 mg, $299 for 5.5 mg and 9 mg, and $349 for the 14.5 mg and 17.2 mg doses — or $299 on the top doses if you refill within 45 days. A realistic first year of cash pricing totals roughly $3,300 to $3,700, not $1,788.
How much weight can you lose on Foundayo?
In its main 72-week trial, people on the top dose lost about 11% of their body weight on average — roughly 25 pounds for someone starting near 230 pounds. More than half of people on the top dose lost at least 10%, and about one in three lost at least 15%. Results build over months and depend on dose, diet, and activity.
What are the most common Foundayo side effects?
The most common side effects are gastrointestinal: nausea, constipation, diarrhea, and vomiting, usually worst when starting or increasing the dose. At the top dose, nausea affected about 35% of people, with constipation, diarrhea, and vomiting around 24-25%. About 3-6% of people in trials stopped because of stomach side effects.
Does Foundayo interact with birth control?
It can. The FDA label advises people on oral hormonal birth control pills to switch to a non-pill method or add a barrier method for 30 days after starting Foundayo and for 30 days after each dose increase. With 6 dose steps, that means potential contraception planning across the first 5 to 6 months. Non-oral hormonal methods (patch, ring, IUD, implant) are not affected.
Can Medicare cover Foundayo?
Starting July 1, 2026, eligible Medicare Part D members may get Foundayo for a $50 monthly copay through the temporary Medicare GLP-1 Bridge, if they take it for weight loss and meet the program's BMI and health criteria. The $50 does not count toward your deductible or out-of-pocket max, and Extra Help (low-income subsidy) does not apply to it. People who take a GLP-1 for diabetes, sleep apnea, or MASH use their regular Part D plan instead.
Can you take Foundayo with another GLP-1?
No. The label advises against using Foundayo at the same time as another GLP-1 receptor agonist, because it can raise the risk of side effects. Discuss any switching plan with your clinician before making changes.
Is there a generic or compounded version of Foundayo?
No. Foundayo is a brand-name, patent-protected medication with no FDA-approved generic and no legitimate compounded version of orforglipron. Treat any 'compounded orforglipron' or 'generic Foundayo' offer as a red flag and steer clear.
Can you take Foundayo with simvastatin?
Yes, but simvastatin must not exceed 20 mg/day while taking Foundayo. Foundayo raises simvastatin levels in your blood even when you stagger doses. Atorvastatin and rosuvastatin do not have the same clinically relevant interaction.
Where can I get Foundayo online?
You can get Foundayo through telehealth providers such as Ro or Sesame Care, Lilly's direct-to-patient service LillyDirect, or your own doctor plus a retail pharmacy. A licensed provider must confirm you qualify before prescribing.
Medical disclaimer: This article is for general education, not medical advice. Foundayo and other GLP-1 medicines are prescription-only and aren't right for everyone. Only a licensed healthcare provider can decide whether a GLP-1 medication is appropriate for your medical history. All pricing, access, and clinical data last verified June 22, 2026.
Sources we checked
- U.S. Food and Drug Administration — Foundayo approval announcement (April 1, 2026)
- DailyMed — official FDA label for Foundayo (orforglipron): indication, dosing, warnings, interactions, and trial results
- Eli Lilly — Foundayo approval and clinical results (investor.lilly.com)
- Foundayo (Eli Lilly) — coverage, savings, and self-pay pricing (foundayo.lilly.com)
- Ro — Foundayo availability, cost, and access (ro.co/press/foundayo/)
- CMS — Medicare GLP-1 Bridge program and eligibility (cms.gov)
- Novo Nordisk — Wegovy pill approval and results
- Eli Lilly / LillyDirect — Zepbound self-pay pricing
- GoodRx — Foundayo retail price and discounts
- Drugs.com — Foundayo user reviews and generic availability
Related guides
The RX Index is an independent editorial publisher covering GLP-1 medications and telehealth providers. We are not affiliated with Eli Lilly, Novo Nordisk, or any drug manufacturer. We may earn a commission if you visit a provider through our links, but this does not influence our editorial content. Last verified June 22, 2026.